Takeda Pharmaceutical Co Stock Today

TAK Stock  USD 13.89  0.30  2.11%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 64

 
100  
 
Zero
Quite High
Takeda Pharmaceutical is selling for 13.89 as of the 28th of March 2024. This is a -2.11% down since the beginning of the trading day. The stock's last reported lowest price was 13.82. Takeda Pharmaceutical has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Takeda Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
27th of October 2008
Category
Healthcare
Classification
Health Care
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. The company has 3.14 B outstanding shares of which 6.26 M shares are at this time shorted by investors with about 3.77 days to cover. More on Takeda Pharmaceutical Co

Moving against Takeda Stock

  0.56ONCT Oncternal Therapeutics Financial Report 2nd of May 2024 PairCorr

Takeda Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Takeda Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Takeda Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
interim President and CEONeil Swift
Old Names[Tap Oil Limited, Tap Oil Limited]
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, ARCA Pharmaceutical, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Takeda Pharmaceutical report their recommendations after researching Takeda Pharmaceutical's financial statements, talking to executives and customers, or listening in on Takeda Pharmaceutical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Takeda Pharmaceutical. The Takeda consensus assessment is calculated by taking the average forecast from all of the analysts covering Takeda Pharmaceutical.
Financial Strength
Based on the analysis of Takeda Pharmaceutical's profitability, liquidity, and operating efficiency, Takeda Pharmaceutical Co may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Takeda Pharmaceutical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.450.33
Significantly Up
Slightly volatile
Gross Profit Margin0.570.62
Significantly Down
Pretty Stable
Total Current LiabilitiesT2.9 T
Sufficiently Up
Slightly volatile
Non Current Liabilities Total6.2 T5.9 T
Sufficiently Up
Slightly volatile
Total Assets16.9 T16.1 T
Sufficiently Up
Slightly volatile
Total Current AssetsT2.8 T
Way Down
Slightly volatile
Total Cash From Operating Activities1.2 T1.1 T
Sufficiently Up
Slightly volatile
Takeda Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Takeda Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Takeda Pharmaceutical's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Takeda Pharmaceutical's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Takeda Pharmaceutical's financial leverage. It provides some insight into what part of Takeda Pharmaceutical's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Takeda Pharmaceutical's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Takeda Pharmaceutical deploys its capital and how much of that capital is borrowed.
Liquidity
Takeda Pharmaceutical cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 4.38 T in debt with debt to equity (D/E) ratio of 0.81, which is OK given its current industry classification. Takeda Pharmaceutical has a current ratio of 1.16, demonstrating that it may have difficulties to pay its financial commitments when the payables are due. Debt can assist Takeda Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Takeda Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Takeda Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Takeda to invest in growth at high rates of return. When we think about Takeda Pharmaceutical's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(2.98 Billion)
Takeda Pharmaceutical Co (TAK) is traded on New York Stock Exchange in USA. It is located in 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 and employs 49,095 people. Takeda Pharmaceutical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 45.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutical's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Takeda Pharmaceutical runs under Pharmaceuticals sector within Health Care industry. The entity has 3.14 B outstanding shares of which 6.26 M shares are at this time shorted by investors with about 3.77 days to cover. Takeda Pharmaceutical Co has about 533.53 B in cash with 977.16 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 208.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Takeda Pharmaceutical Probability Of Bankruptcy
Ownership Allocation
Takeda Pharmaceutical shows a total of 3.14 Billion outstanding shares. About 97.0 % of Takeda Pharmaceutical outstanding shares are held by general public with 2.66 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Takeda Ownership Details

Takeda Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Takeda Pharmaceutical jumping above the current price in 90 days from now is about 99.0%. The Takeda Pharmaceutical Co probability density function shows the probability of Takeda Pharmaceutical stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Takeda Pharmaceutical has a beta of 0.0425. This usually implies as returns on the market go up, Takeda Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Takeda Pharmaceutical Co will be expected to be much smaller as well. Additionally, takeda Pharmaceutical Co has an alpha of 0.0134, implying that it can generate a 0.0134 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 13.89HorizonTargetOdds Above 13.89
1.04%90 days
 13.89 
98.92%
Based on a normal probability distribution, the odds of Takeda Pharmaceutical to move above the current price in 90 days from now is about 99.0 (This Takeda Pharmaceutical Co probability density function shows the probability of Takeda Stock to fall within a particular range of prices over 90 days) .

Takeda Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Takeda Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Takeda Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Takeda Pharmaceutical's value.
InstituionRecorded OnShares
Northern Trust Corp2023-12-31
1.8 M
Blackrock Inc2023-12-31
1.8 M
Managed Asset Portfolios, Llc2023-12-31
1.8 M
Envestnet Asset Management Inc2023-12-31
1.6 M
Causeway Capital Management Llc2023-12-31
1.3 M
Van Eck Associates Corporation2023-12-31
1.3 M
Y.d. More Investments Ltd2023-12-31
1.3 M
Old Mission Capital Llc2023-12-31
M
Bank Of America Corp2023-12-31
834.3 K
Capital Research Global Investors2023-12-31
14.3 M
Goldman Sachs Group Inc2023-12-31
8.6 M
View Takeda Pharmaceutical Diagnostics

Takeda Pharmaceutical Historical Income Statement

Takeda Pharmaceutical Co Income Statement is one of the three primary financial statements used for reporting Takeda's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Takeda Pharmaceutical revenue and expense. Takeda Pharmaceutical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Takeda Pharmaceutical's EBITDA is quite stable compared to the past year. Cost Of Revenue is expected to rise to about 1.5 T this year, although the value of EBIT will most likely fall to about 256.1 B. View More Fundamentals

Takeda Stock Against Markets

Picking the right benchmark for Takeda Pharmaceutical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Takeda Pharmaceutical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Takeda Pharmaceutical is critical whether you are bullish or bearish towards Takeda Pharmaceutical Co at a given time. Please also check how Takeda Pharmaceutical's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Takeda Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Takeda Pharmaceutical Corporate Directors

Takeda Pharmaceutical corporate directors refer to members of a Takeda Pharmaceutical board of directors. The board of directors generally takes responsibility for the Takeda Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Takeda Pharmaceutical's board members must vote for the resolution. The Takeda Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
C WasserDirectorProfile
Lori WaltonDirectorProfile
JeanLuc ButelIndependent DirectorProfile
Michel OrsingerIndependent DirectorProfile

How to buy Takeda Stock?

Before investing in Takeda Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Takeda Pharmaceutical. To buy Takeda Pharmaceutical stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Takeda Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Takeda Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Takeda Pharmaceutical Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Takeda Pharmaceutical Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Takeda Pharmaceutical Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Takeda Stock please use our How to Invest in Takeda Pharmaceutical guide.

Already Invested in Takeda Pharmaceutical Co?

The danger of trading Takeda Pharmaceutical Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Takeda Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Takeda Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Takeda Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Takeda Stock analysis

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is Takeda Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
184
Earnings Share
0.37
Revenue Per Share
1.3 K
Quarterly Revenue Growth
0.013
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.